| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
5 companies
Fouse Jacqualyn A is a Director at AGIOS PHARMACEUTICALS, INC. with holdings across 5 companies. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $21.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 7,497 | $25.90 | $194,172.30 | -4.8% | +54.4% | +30.1% | |
| Apr 10, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 7,791 | $27.55 | $214,642.05 | -5.4% | +42.6% | -15.5% | |
| Jan 24, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 10,722 | $21.64 | $232,024.08 | -7.7% | +47.9% | +64.5% | |
| Jan 9, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 8,391 | $22.99 | $192,909.09 | -6.7% | +15.4% | +49.6% | |
| Jun 30, 2023 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 10,718 | $28.36 | $303,962.48 | -9.1% | -12.5% | +52.3% | |
| Nov 13, 2019 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 40,322 | $31.00 | $1,249,982.00 | +2,880% | - | - |